146 related articles for article (PubMed ID: 38171860)
1. A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report.
Shibuya R; Baba K; Furuta R; Maesaka H; Hirosawa H; Bando T; Oshima A; Onoda H; Nukui T; Dougu N; Joho S; Nakatsuji Y
Intern Med; 2024 Jan; ():. PubMed ID: 38171860
[TBL] [Abstract][Full Text] [Related]
2. The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma.
Jeyakumar N; Etchegaray M; Henry J; Lelenwa L; Zhao B; Segura A; Buja LM
Case Reports Immunol; 2020; 2020():5126717. PubMed ID: 32695533
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis.
Saito S; Hontsu S; Hiraoka J; Yamanaka A; Fujioka N; Shimada D; Okuda Y; Sugie K; Muro S
Intern Med; 2024 Apr; ():. PubMed ID: 38658343
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.
Niimura T; Zamami Y; Miyata K; Mikami T; Asada M; Fukushima K; Yoshino M; Mitsuboshi S; Okada N; Hamano H; Sakurada T; Matsuoka-Ando R; Aizawa F; Yagi K; Goda M; Chuma M; Koyama T; Izawa-Ishizawa Y; Yanagawa H; Fujino H; Yamanishi Y; Ishizawa K
J Clin Pharmacol; 2023 Apr; 63(4):473-479. PubMed ID: 36453166
[TBL] [Abstract][Full Text] [Related]
5. Sintilimab-Induced Myocarditis Overlapping Myositis in a Patient With Metastatic Thymoma: A Case Report.
Yang ZX; Chen X; Tang SQ; Zhang Q
Front Cardiovasc Med; 2021; 8():797009. PubMed ID: 35004910
[TBL] [Abstract][Full Text] [Related]
6. Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment.
Luo YB; Tang W; Zeng Q; Duan W; Li S; Yang X; Bi F
Front Cardiovasc Med; 2021; 8():714460. PubMed ID: 34485412
[TBL] [Abstract][Full Text] [Related]
7. Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report.
Cham J; Ng D; Nicholson L
J Med Case Rep; 2021 May; 15(1):278. PubMed ID: 34053457
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.
Deharo F; Carvelli J; Cautela J; Garcia M; Sarles C; Maues de Paula A; Bourenne J; Gainnier M; Bichon A
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233479
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report.
Saishu Y; Yoshida T; Seino Y; Nomura T
J Med Case Rep; 2022 Feb; 16(1):61. PubMed ID: 35152911
[TBL] [Abstract][Full Text] [Related]
10. Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature.
Yin B; Xiao J; Wang X; Li X; Guan Y; Chen J; Han P; Li K; Wang J
Front Med (Lausanne); 2022; 9():950801. PubMed ID: 36457566
[TBL] [Abstract][Full Text] [Related]
11. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.
Jespersen MS; Fanø S; Stenør C; Møller AK
Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082
[TBL] [Abstract][Full Text] [Related]
12. [Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report].
Sugiyama Y; Esa Y; Watanabe A; Kobayashi J; Suzuki S; Takahashi D
Rinsho Shinkeigaku; 2021 Sep; 61(9):630-634. PubMed ID: 34433744
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome.
Giglio D; Berntsson H; Fred Å; Ny L
Case Rep Oncol; 2020; 13(3):1252-1257. PubMed ID: 33250739
[TBL] [Abstract][Full Text] [Related]
15. [A case of myasthenia gravis and myositis induced by pembrolizumab].
Noda T; Kageyama H; Miura M; Tamura T; Ito H
Rinsho Shinkeigaku; 2019 Aug; 59(8):502-508. PubMed ID: 31341124
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis with inclusion body myositis: A case report.
Kakutani T; Yoshizawa M
Mod Rheumatol Case Rep; 2023 Dec; 8(1):83-85. PubMed ID: 37210209
[TBL] [Abstract][Full Text] [Related]
17. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
[TBL] [Abstract][Full Text] [Related]
18. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
[TBL] [Abstract][Full Text] [Related]
19. Novel uses of complement inhibitors in myasthenia gravis-Two case reports.
Zadeh S; Price H; Drews R; Bouffard MA; Young LH; Narayanaswami P
Muscle Nerve; 2024 Mar; 69(3):368-372. PubMed ID: 38205840
[TBL] [Abstract][Full Text] [Related]
20. Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report.
Zhou Z; Chen X; Liu G; Pu J; Wu J
Front Neurol; 2019; 10():770. PubMed ID: 31379720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]